Price (delayed)
$4.85
Market cap
$26.53M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.99
Enterprise value
$49.11M
Pluristem Therapeutics Inc. is a leading regenerative medicine company developing novel placenta-based cell therapy product candidates. The Company has reported robust clinical trial data in multiple indications for its patented
There are no recent dividends present for PLUR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.